[go: up one dir, main page]

MX2008011178A - Agente profilàctico o terapèutico para enfermedad oftàlmica alèrgica o enfermedad nasal alèrgica, que comprende derivado tricìclico de triazolobenzacepina. - Google Patents

Agente profilàctico o terapèutico para enfermedad oftàlmica alèrgica o enfermedad nasal alèrgica, que comprende derivado tricìclico de triazolobenzacepina.

Info

Publication number
MX2008011178A
MX2008011178A MX2008011178A MX2008011178A MX2008011178A MX 2008011178 A MX2008011178 A MX 2008011178A MX 2008011178 A MX2008011178 A MX 2008011178A MX 2008011178 A MX2008011178 A MX 2008011178A MX 2008011178 A MX2008011178 A MX 2008011178A
Authority
MX
Mexico
Prior art keywords
allergic
disease
prophylactic
triazolobenzoazepine
tricyclic
Prior art date
Application number
MX2008011178A
Other languages
English (en)
Inventor
Takashi Shishikura
Tsuneyoshi Inaba
Yukari Hoshina
Hirotomo Akabane
Mitsuhiro Uchida
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Publication of MX2008011178A publication Critical patent/MX2008011178A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se divulga una composición farmacéutica para prevenir o tratar una enfermedad oftálmica alérgica o una enfermedad nasal alérgica, que comprende 7,8-dimetoxi-4(5H),10-dioxo-1H-1,2,3,-tria zolo[4,5-c][1]benzoacepina o 2-(1-isopropoxi-carboniloxi-2-metilpr opil)-7,8-dimetoxi-4(5H),10-dioxo-2H-1,2,3,-triazolo-[4,5-c][1]be nzoacepina, o una sal farmacéuticamente aceptable. La composición farmacéutica produce pocos efectos colaterales adversos y tiene un efecto profiláctico potente y un efecto terapéutico potente en una fase tardía cuando se puede inducir la resistencia al tratamiento contra una gota oftálmica ya disponible. La composición puede ser utilizada adecuadamente para administración tópica.
MX2008011178A 2006-03-02 2007-03-02 Agente profilàctico o terapèutico para enfermedad oftàlmica alèrgica o enfermedad nasal alèrgica, que comprende derivado tricìclico de triazolobenzacepina. MX2008011178A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2006055711 2006-03-02
JP2006055706 2006-03-02
PCT/JP2007/054008 WO2007100079A1 (ja) 2006-03-02 2007-03-02 三環性トリアゾロベンゾアゼピン誘導体を含有する、アレルギー性眼疾患またはアレルギー性鼻疾患の予防または治療剤

Publications (1)

Publication Number Publication Date
MX2008011178A true MX2008011178A (es) 2008-09-25

Family

ID=38459174

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008011178A MX2008011178A (es) 2006-03-02 2007-03-02 Agente profilàctico o terapèutico para enfermedad oftàlmica alèrgica o enfermedad nasal alèrgica, que comprende derivado tricìclico de triazolobenzacepina.

Country Status (9)

Country Link
US (1) US7910575B2 (es)
EP (1) EP1994931A4 (es)
JP (1) JPWO2007100079A1 (es)
KR (1) KR20080110760A (es)
CN (1) CN101432000B (es)
BR (1) BRPI0708448A2 (es)
CA (1) CA2644810A1 (es)
MX (1) MX2008011178A (es)
WO (1) WO2007100079A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI544922B (zh) 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
CN113671064B (zh) * 2021-07-15 2022-05-17 中国海洋大学 一种定量分析血浆中氨来占诺的血药浓度的检测方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4477464A (en) * 1983-02-10 1984-10-16 Ciba-Geigy Corporation Hetero-benzazepine derivatives and their pharmaceutical use
US5686442A (en) 1993-12-28 1997-11-11 Meiji Seika Kabushiki Kaisha Tricyclic benzazepine and benzothiazepine derivatives
EP0834512A4 (en) * 1995-06-15 2001-08-22 Meiji Seika Kaisha TRICLYCLIC BENZAZEPINE COMPOUNDS.
AU744636B2 (en) * 1997-09-29 2002-02-28 Meiji Seika Pharma Co., Ltd. Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic
ATE410427T1 (de) 2001-12-26 2008-10-15 Meiji Seika Kaisha Neues kristallines tricyclisches triazolobenzazepinderivat
JPWO2004113343A1 (ja) 2003-06-19 2006-08-31 明治製菓株式会社 三環性トリアゾロベンゾアゼピン誘導体の新規結晶性物質
JP4310643B2 (ja) 2004-08-18 2009-08-12 株式会社石垣 回転濃縮機における原液供給装置
JP4528578B2 (ja) 2004-08-18 2010-08-18 日立建機株式会社 木材破砕機

Also Published As

Publication number Publication date
US7910575B2 (en) 2011-03-22
CN101432000B (zh) 2012-04-18
KR20080110760A (ko) 2008-12-19
BRPI0708448A2 (pt) 2011-06-07
WO2007100079A1 (ja) 2007-09-07
JPWO2007100079A1 (ja) 2009-07-23
CN101432000A (zh) 2009-05-13
EP1994931A1 (en) 2008-11-26
CA2644810A1 (en) 2007-09-07
EP1994931A4 (en) 2010-12-01
US20090012058A1 (en) 2009-01-08

Similar Documents

Publication Publication Date Title
WO2002066480A3 (en) 2-arylamino-pyrimidines for the treatment of gsk3-related disorders
WO2006082588A3 (en) Method and device for ophthalmic administration of active pharmaceutical ingredients
WO2005065646A3 (en) Novel drug compositions and dosage forms
UA94909C2 (ru) Фармацевтическая композиция нейроактивного стероида и ее применение
ATE529417T1 (de) 3',4',5-trimethoxyflavonderivate als die schleimsekretion stimulierendes mittel, entsprechendes verfahren und pharmazeutische zusammensetzung, die diese enthält
UA92000C2 (en) 1-benzylindole-2-carboxamide derivatives
WO2009109616A3 (en) 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cxrl and p40
WO2007092469A3 (en) Combination of organic compounds
WO2011074015A3 (en) Composition of pharmaceutical product to treat sexual dysfunction
MX2009005798A (es) Recuperacion de apoplejia.
WO2005107810A3 (en) Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction
NO20092764L (no) Isosorbid mononitrat derivater for behandling av okular hypertensjon
EA200601418A1 (ru) ПРОИЗВОДНЫЕ 1Н-ТИЕНО [2,3-с] ПИРАЗОЛА, ПРЕДНАЗНАЧЕННЫЕ ДЛЯ ИСПОЛЬЗОВАНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ КИНАЗЫ
WO2008051527A3 (en) Sustained release of agents for localized pain management
WO2006060731A3 (en) Use of atazanavir for improving the pharmacokinetics of drugs metabolized by ugt1a1
MX2008011178A (es) Agente profilàctico o terapèutico para enfermedad oftàlmica alèrgica o enfermedad nasal alèrgica, que comprende derivado tricìclico de triazolobenzacepina.
WO2006002096A3 (en) Low doses of l-citrulline for treating diseases
WO2006125194A3 (en) Piperazine derivatives and their uses as therapeutic agents
WO2007064448A3 (en) Cancer treatment using fts and 2-deoxyglucose
CA2432177A1 (en) Drug for prevention and/or therapy of endometriosis
AU2003257589A1 (en) Remedy for integration dysfunction syndrome
WO2007062862A3 (en) Use of calmodulin inhibitors for the treatment of neurodegenerative disorders
WO2005121074A3 (en) Processes for the preparation of sertraline hydrochloride
WO2004073627A3 (en) Novel therapeutic method and compositions for topical administration
WO2009078444A1 (ja) 炎症性腸疾患の予防または治療剤

Legal Events

Date Code Title Description
HC Change of company name or juridical status
FG Grant or registration